Skip to main content
. 2015 Oct 15;8:2949–2957. doi: 10.2147/OTT.S79145

Table 2.

Biochemical activities of regorafenib in in vitro kinase assays

Kinase targets55 Regorafenib IC50 (nM) ± SD
VEGFR1 13±0.4
TIE2 311±46
PDGFR-β 22±3
FGFR1 202±18
KIT 7±2
RET 1.5±0.7
RAF-1 2.5±0.6
B-RAF 2.5±10
B-RAFV600E 19±6

Abbreviations: IC50, inhibitory concentration of 50%; SD, standard deviation.